Predictors of outcome in the early course of first-episode psychosis

European Journal of Psychiatry

Volumn 24, Issue 2, 2010, Pages 87-97

  Gómez de Regil, Lizzette ^a   Kwapil, Thomas R ^b   Blanqué, Joan Manel ^c   Vainer, Elias ^c   Montoro, Mónica ^c   Barrantes Vidal, Neus ^a,c,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Fundacio Hospital Sant Pere Claver   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

First episode psychosis; Illness course; Outcome criteria; Outcome predictors; Schizophrenia

Indexed keywords

ADJUSTMENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MALE; MARRIAGE; PREDICTION; PREDICTIVE VALIDITY; PROGNOSIS; PSYCHOSIS; RELAPSE; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 77954669416     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: 10.4321/S0213-61632010000200004     Document Type: Article

References (37)

1. Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis: A research update. Am J Psychiatry 2005; 162(12): 2220-2232.
2. Barnes TRE, Pant A. Long-term course and outcome of schizophrenia. Psychiatry 2005; 4(10): 29-32.
3. McGorry PD. "A stitch in time"... the scope for preventive strategies in early psychosis. Eur Arch Psychiatry Clin Neurosci 1998; 248(1): 22-31.
4. Rosen K, Garety P. Predicting recovery from schizophrenia: A retrospective comparison of characteristics at onset of people with singe and multiple episodes. Schizophr Bull 2005; 31(3): 735-750.
5. Malla AK, Norman RMG, Joober R. First-episode psychosis, early intervention, and outcome: What have we learned? Can J Psychiatry 2005; 50(14): 881-891.
6. Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 2006; 36(10): 1349-1362.
7. American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, D.C.: American Psychiatric Association; 2000.
8. Marneros A, Deister A, Rohde A. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand 1990; 82(5): 352-358.
9. Möller H, Bottlender R, Wegner U, Wittmann J, Strauß A. Long-term course of schizophrenic, affective and schizoaffective psychosis: Focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand 2000; 102: 54-57.
10. Ciompi L. The natural history of schizophrenia in the long term. Br J Psychiatry 1980; 136: 413-420.
11. Jablensky A, Sartorius N, Ernberg G, Anker M. Schizophrenia: Manifestations, incidence and course in different cultures: A world health organization ten-country study. Psychol Med 1992; 20: 1-97.
12. Shepherd M,Watt D, Falloon I, Smeeton N. The natural history of schizophrenia: A five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med 1989; 15: 1-46.
13. Vázquez-Barquero JL, Cuesta MJ, Castanedo SH, Lastra I, Herrán A, Dunn G. Cantabria first-episode schizophrenia study: Three-year follow-up. Br J Psychiatry 1999; 174: 141-149.
14. Altamura AC, Bassetti R, Sassella F, Salvadori D, Mundo E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: A retrospective study. Schizophr Res 2001; 52(1): 29-36.
15. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, 'just the facts': What we know in 2008: Part 1: Overview. Schizophr Res 2008; 100(1): 4-19.
16. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus. Am J Psychiatry 2005; 162: 441-449.
17. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003; 28: 17-54.
18. Ochoa S, Usall J, Villalta-Gil V, Vilaplana M, Márquez M, Valdelomar M, et al. Influence of age at onset on social functioning in outpatients with schizophrenia. Eur J Psychiat 2006; 20(3): 157-163.
19. Usall J, Haro JM, Araya S, Moreno B, Muñoz PE, Martínez A, et al. Social functioning in schizophrenia: what is the influence of gender?. Eur J Psychiat 2007; 21(3): 199-205.
20. Usall J. Diferencias de género en la esquizofrenia. Rev Psiquiatría Fac Med Barna 2003; 30(5): 276-287.
21. Salem JE, Kring AM. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 1998; 18(7): 795-819.
22. Jablensky A, Cole SW. Is the earlier age at onset of schizophrenia in males a confounded finding? Results from a cross-cultural investigation. Br J Psychiatry 1997; 170(3): 234-240.
23. Haim R, Rabinowitz J, Bromet E. The relationship of premorbid functioning to illness course in schizophrenia and psychotic mood disorders during two years following first hospitalization. J Nerv Ment Dis 2006; 194(10): 791-795.
24. Caton CLM, Hasin DS, Shrout PE, Drake RE, Dominguez B, Samet S, et al. Predictors of psychosis remission in psychotic disorders that co-occur with substance use. Schizophr Bull 2006; 32(4): 618-625.
25. McEvoy JP, Johnson J, Perkins D, Lieberman JA, Hamer RM, Keefe RSE, et al. Insight in first-episode psychosis. Psychol Med 2006; 36(10): 1385-1393.
26. Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC. Lack of insight in schizophrenia: Impact on treatment adherence. CNS Drugs 2007; 21(2): 129-141.
27. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004; 71(2): 405-416.
28. Kwapil TR. Social anhedonia as predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol 1998; 107(4): 558-565.
29. Johnstone EC, Ebmeier KP, Miller P, Owens DGC, Lawrie, SM. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005; 186: 18-25.
30. Cuesta MJ, Peralta V, Gil P, Artamendi M. Premorbid negative symptoms in first-episode psychosis. Eur J Psychiat 2007; 21(3): 220-229.
31. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004; 71(2): 405-416.
32. Tsuang MT, Stone WS, Faraone SV. Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry 2000; 157(7): 1041-1050.
33. Kane J. Progress defined-short-term efficacy, longterm effectiveness. Int Clin Psychopharmacol 2001; 16: s1-s8.
34. Taylor M, Chaudhry I, Cross M, McDonald E, Miller P, Pilowsky L, et al. Towards consensus in the longterm management of relapse prevention in schizophrenia. Hum Psychopharmacol Clin Exp 2005; 20(3): 175-181.
35. Nasrallah HA, Lasser R. Improving patient outcomes in schizophrenia: Achieving remission. J Psychopharmacol 2006; 20(6): 57-61.
36. Di Marzo S, Giordano A, Pacchiarotti I, Colom F, Sánchez-Moreno J, Vieta E. The impact of the number of episodes on the outcome of Bipolar Disorder. Eur J Psychiat 2006; 20(1): 21-28.
37. Lincoln TM, Lüllmann E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull 2007; 33(6): 1324-1342.